New Research Explores How Mosquito Bites May Trigger Protection Against Malaria
Researchers explore mosquito-based approaches to malaria protection.
Scientists from the Walter and Eliza Hall Institute of Medical Research (WEHI) in Australia have developed an experimental approach that could potentially turn malaria-infected mosquito bites into vaccine-like boosters. The research, published in Science, found that the strategy provided mice with extended protection against malaria. However, the findings are still at the preclinical stage, and researchers have stressed that people should not deliberately expose themselves to malaria-infected mosquitoes.
The approach works by using an antimalarial drug to stop the malaria parasite during a specific stage of its development inside the liver. Normally, parasites introduced by an infected mosquito travel to the liver, multiply and eventually enter the bloodstream, where they cause malaria. In the study, researchers used experimental compounds called WM382 and MK-7602 to block proteins known as plasmepsin IX and X, preventing the parasite from progressing to the disease-causing stage.
By stopping the parasite near the end of its liver-stage development, researchers allowed the immune system to encounter more of the parasite without allowing it to reach the bloodstream. This effectively gave the immune system a fuller preview of the pathogen. The researchers found that the approach triggered both antibody responses and CD8+ T-cell responses, including liver-resident memory T cells that could potentially respond rapidly when the parasite was encountered again.
Also Read: Foreigner Receives Free Malaria, Dengue Screening At Surat Government Hospital
The liver stage is particularly important because malaria parasites spend part of their life cycle there before moving into the blood. Scientists have long explored ways of targeting the parasite during this stage, as eliminating it before it reaches the bloodstream could prevent the development of malaria. The new research takes advantage of this window by allowing controlled parasite development while using medication to prevent progression to illness.
Researchers also found that subsequent mosquito bites carrying malaria parasites could strengthen the immune response produced by the initial exposure. This led the scientists to describe the concept as a possible "vaccinate and boost naturally" approach. In theory, controlled exposure could provide repeated immune stimulation, but such a strategy would require carefully controlled drug protection and extensive testing before it could ever be considered for people.
Justin Boddey, an associate professor at WEHI, described the findings as a shift in how drugs could potentially be used alongside malaria prevention strategies. The researchers said the immune response in mice was broader and longer lasting than some existing vaccine approaches. However, the study does not establish that the method is safe or effective in humans, and further research will be required to determine whether the experimental strategy can eventually be developed into a practical malaria prevention method.
Also Read: Exosome Therapy For Hair Loss: What Dermatologists Say About It
